Valiant Laboratories Ltd. IPO

Valiant Laboratories Limited (VLL) is a leading Indian API/Bulk Drug company manufacturing Paracetamol, a widely used analgesic and antipyretic drug. Founded in 1980, VLL has a strong reputation for quality and compliance, with a focus on R&D and continuous process improvement. VLL is well-managed with a strong track record of growth and is committed to sustainability.

RHP
View
DRHP
View
Open Date

2023-09-27

Close Date

2023-10-03

Company Financials

You can get the following financial statements of Valiant Laboratories Ltd. as of now.

Subscription Details

The details about the Valiant Laboratories Limited IPO is as:

  • The issue size of the IPO is 152.46 Cr.
  • The price band for Valiant Laboratories Limited IPO is Rs 133 to Rs 140.
  • The shares of Valiant Laboratories Limited IPO will list on 6th October 2023.
  • The latest tentative GMP of Valiant Laboratories Limited IPO is Rs 15.
  • The shares of Valiant Laboratories Limited IPO is subscribed 29.75 Times as of 3rd October 2023.

 

Valiant Laboratories Limited IPO Valuation

The approx valuation of Valiant Laboratories Limited IPO company based on its price band and DRHP (prospectus) is: 

Particulars Value
Upper Price Band Rs 140
Existing Shares (Qty) 3.25 Cr
Fresh Issue 152.46 Cr
Market Cap 495.49 Cr
EPS (FY23) Rs 8.91
PE Ratio 15.71x
Industry PE 18.12x

 

Valiant Laboratories Limited IPO Issue Size

Valiant Laboratories Limited IPO issue size is 152.46 Cr. 

Issue Amount
Fresh Issue 152.46 Cr
Offer For Sale 0 Cr

  

Valiant Laboratories Limited IPO Market Lot

An Individual can apply for a minimum 1 lot of 105 shares and a maximum of 13 lots of 1365 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 105 14,700
 Maximum 13 1365 1,91,100

 

Valiant Laboratories Limited IPO share offer

The shares of Valiant Laboratories Limited IPO is subscribed 29.75 Times as of 3rd October 2023. The category-wise shares offered are as follows:

Category % Offered Subscription
Qualified Institutional Maximum 50% 20.83 Times
Non-Institutional Minimum 15% 73.63 Times
Retail Individual Minimum 35% 16.05 Times
Total   29.75 Times

 

Allotment Details

Find below the dates for Valiant Laboratories Limited IPO:

Schedule Date
Basis of Allotment 5 October 2023
Refunds 6 October 2023
Credit to Demat Account 6 October 2023
IPO Listing Date 6 October 2023

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023
Net Sales 291.52 333.91
Total Expenditure 249.21 298.82
Operating Profit 42.32 35.09
Other Income 1.95 4.86
Interest 0.07 0.25
Depreciation 2.49 1.56
Exceptional Items 0 0
Profit Before Tax 41.7 38.14
Provision for Tax 14.21 9.14
Net Profit 27.5 29
Adjusted EPS (Rs.) 0.84 0.89

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 16.28 32.56
Total Reserves 55.18 67.93
Borrowings 59.4 59.4
Other N/C liabilities 1.52 2.35
Current liabilities 49.43 50.52
Total Liabilities 181.81 212.76
Assets
Net Block 22.23 29.97
Capital WIP 1.45 0.05
Intangible WIP 0 0
Investments 0 0.01
Loans & Advances 1.34 0.77
Other N/C Assets 0 0
Current Assets 156.8 181.96
Total Assets 181.81 212.76
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024
Other Income 2.96 1.78 2.5
Profit Before Tax 1.06 -5.05 -2.55
Tax 0.27 -1.54 -1.33
Profit After Tax 0.79 -3.5 -1.22
Adjusted EPS (Rs) 0.24 -0.81 -0.28

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 74.94 0
Dec 2023 74.94 0
Sep 2023 74.94 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023
Profit from operations 41.7 38.14
Adjustment 3.07 1.82
Changes in Assets & Liabilities -28.05 -8.2
Tax Paid -14.47 -8.8
Operating Cash Flow 2.25 22.96
Investing Cash Flow -12.24 -21.18
Financing Cash Flow 6.18 -1.54
Net Cash Flow -3.81 0.24
X